These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10862607)

  • 1. The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding.
    Bhattacharjee G; Asplin IR; Wu SM; Gawdi G; Pizzo SV
    J Biol Chem; 2000 Sep; 275(35):26806-11. PubMed ID: 10862607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin.
    Soker S; Svahn CM; Neufeld G
    J Biol Chem; 1993 Apr; 268(11):7685-91. PubMed ID: 7681826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of platelet-derived growth factor-BB and transforming growth factor-beta 1 to alpha 2-macroglobulin in vitro and in vivo: comparison of receptor-recognized and non-recognized alpha 2-macroglobulin conformations.
    Crookston KP; Webb DJ; Lamarre J; Gonias SL
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):443-50. PubMed ID: 7688216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical or overlapping sequences in the primary structure of human alpha(2)-macroglobulin are responsible for the binding of nerve growth factor-beta, platelet-derived growth factor-BB, and transforming growth factor-beta.
    Gonias SL; Carmichael A; Mettenburg JM; Roadcap DW; Irvin WP; Webb DJ
    J Biol Chem; 2000 Feb; 275(8):5826-31. PubMed ID: 10681572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.
    Soker S; Fidder H; Neufeld G; Klagsbrun M
    J Biol Chem; 1996 Mar; 271(10):5761-7. PubMed ID: 8621443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors.
    Soker S; Goldstaub D; Svahn CM; Vlodavsky I; Levi BZ; Neufeld G
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1339-47. PubMed ID: 7522446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous up-regulation of KDR/Flk-1 receptor expression by vascular endothelial growth factor in vitro.
    Shen BQ; Lee DY; Gerber HP; Keyt BA; Ferrara N; Zioncheck TF
    J Biol Chem; 1998 Nov; 273(45):29979-85. PubMed ID: 9792718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected].
    Gluzman-Poltorak Z; Cohen T; Herzog Y; Neufeld G
    J Biol Chem; 2000 Jun; 275(24):18040-5. PubMed ID: 10748121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
    Zeng H; Zhao D; Yang S; Datta K; Mukhopadhyay D
    J Biol Chem; 2003 Jun; 278(23):20738-45. PubMed ID: 12670961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased vascular endothelial growth factor 165 binding to kinase insert domain-containing receptor after infection of human endothelial cells by recombinant adenovirus encoding the Vegf(165) gene.
    Weisz A; Koren B; Cohen T; Neufeld G; Kleinberger T; Lewis BS; Flugelman MY
    Circulation; 2001 Apr; 103(14):1887-92. PubMed ID: 11294808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121).
    Whitaker GB; Limberg BJ; Rosenbaum JS
    J Biol Chem; 2001 Jul; 276(27):25520-31. PubMed ID: 11333271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms.
    Gengrinovitch S; Greenberg SM; Cohen T; Gitay-Goren H; Rockwell P; Maione TE; Levi BZ; Neufeld G
    J Biol Chem; 1995 Jun; 270(25):15059-65. PubMed ID: 7797488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E; Schatteman G; Wu T; Kim EA; Varticovski L; Keyt B; Isner JM
    J Clin Invest; 1996 Jan; 97(2):469-76. PubMed ID: 8567969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells.
    Gitay-Goren H; Cohen T; Tessler S; Soker S; Gengrinovitch S; Rockwell P; Klagsbrun M; Levi BZ; Neufeld G
    J Biol Chem; 1996 Mar; 271(10):5519-23. PubMed ID: 8621410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells.
    Kupprion C; Motamed K; Sage EH
    J Biol Chem; 1998 Nov; 273(45):29635-40. PubMed ID: 9792673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation.
    Sahni A; Francis CW
    Blood; 2000 Dec; 96(12):3772-8. PubMed ID: 11090059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase insert domain receptor (KDR) extracellular immunoglobulin-like domains 4-7 contain structural features that block receptor dimerization and vascular endothelial growth factor-induced signaling.
    Tao Q; Backer MV; Backer JM; Terman BI
    J Biol Chem; 2001 Jun; 276(24):21916-23. PubMed ID: 11399777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cells.
    Bocci G; Danesi R; Fioravanti A; Del Tacca M
    Pharmacol Res; 2002 Jan; 45(1):21-5. PubMed ID: 11820857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix.
    Poltorak Z; Cohen T; Sivan R; Kandelis Y; Spira G; Vlodavsky I; Keshet E; Neufeld G
    J Biol Chem; 1997 Mar; 272(11):7151-8. PubMed ID: 9054410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.